T1	Participants 436 506	Sixty qualifying subjects were randomly assigned either to Regimen One
T2	Participants 863 920	They were instructed in the use of their assigned product
T3	Participants 1175 1271	All three treatment groups had statistically significant (p < 0.0001) mean total MLSI reductions
